Dr. Ian J. Welsby, MD

Dr. Welsby practices at Duke University Hospital in Durham, North Carolina, part of Duke University.

Dr. Welsby's NPI, 1245314160, was assigned on October 25, 2006. Dr. Welsby graduated from Middlesex University School of Medicine in 1990. Dr. Welsby holds North Carolina license 96-00802.

Dr. Welsby's primary practice is Duke University Hospital, at 2301 Erwin Rd, Durham, NC 27705 in Durham County. The practice phone is (919) 684-8111.

Dr. Welsby's primary practice is Duke University Hospital in Durham, North Carolina, part of Duke University. The medical group on file is Duke Health Integrated Practice.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Welsby practices. Vendor and product names are available with a free account.

Anesthesiology is Dr. Welsby's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dr. Welsby is licensed in North Carolina.

CMS data shows 142 Medicare services from Dr. Welsby across 5 procedure codes in 2024, for 86 Medicare patients. Medicare paid $14,240 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 86 Medicare patients who saw Dr. Welsby in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Welsby's median patient age at 67, with 33% women.

Dr. Welsby accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 108 papers to Dr. Welsby, published from 2003 to 2025. 2020 was the busiest year, with 12. The most frequent topics are Anticoagulants, Cardiac Surgical Procedures and Postoperative Hemorrhage. Dr. Welsby has published most often in J Cardiothorac Vasc Anesth. Dr. Welsby's most frequent co-authors are Thomas Lee Ortel, MD, Carmelo A. Milano, MD and Jacob Niall Schroder, MD.

Dmand AI links Dr. Welsby to 5 clinical trials, 2 of them phase 4 studies. Conditions studied include Acute Kidney Injury, Acute Lung Injury and Anemia, Sickle Cell. Duke University sponsors the most, 3.

CMS Open Payments shows 44 general payments to Dr. Welsby from 13 drug and device companies from 2016 to 2025. Education make up the largest share, 40% of the total. Zimmer Biomet Holdings, Inc. paid the most, $29,097.

Dr. Welsby graduated from Middlesex University School of Medicine in 1990.